{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:10:53Z","timestamp":1791047453133,"version":"4.1.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/cji.0b013e3181ad4071","type":"journal-article","created":{"date-parts":[[2009,7,17]],"date-time":"2009-07-17T03:24:09Z","timestamp":1247801049000},"page":"726-736","source":"Crossref","is-referenced-by-count":28,"title":["Genetic Modification of T Cells With IL-21 Enhances Antigen Presentation and Generation of Central Memory Tumor-specific Cytotoxic T-lymphocytes"],"prefix":"10.1097","volume":"32","author":[{"given":"Anjum S.","family":"Kaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald R.","family":"Shaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Hartmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Leen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adham","family":"Bear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cliona M.","family":"Rooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron E.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210227","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1182\/blood-2007-05-091280","article-title":"Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer","volume":"110","author":"Bollard","year":"2007","journal-title":"Blood"},{"key":"R2-5-20210227","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1182\/blood-2008-05-157222","article-title":"Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients","volume":"113","author":"Louis","year":"2009","journal-title":"Blood"},{"key":"R3-5-20210227","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1200\/JCO.2005.00.240","article-title":"Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma","volume":"23","author":"Dudley","year":"2005","journal-title":"J Clin Oncol"},{"key":"R4-5-20210227","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1084\/jem.192.11.1637","article-title":"Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo","volume":"192","author":"Yee","year":"2000","journal-title":"J Exp Med"},{"key":"R5-5-20210227","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00002371-200107000-00012","article-title":"Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma","volume":"24","author":"Dudley","year":"2001","journal-title":"J Immunother"},{"key":"R6-5-20210227","doi-asserted-by":"crossref","first-page":"16168","DOI":"10.1073\/pnas.242600099","article-title":"Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells","volume":"99","author":"Yee","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"R7-5-20210227","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00002371-200205000-00007","article-title":"A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma","volume":"25","author":"Dudley","year":"2002","journal-title":"J Immunother"},{"key":"R8-5-20210227","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.1882","article-title":"Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma","volume":"14","author":"Pule","year":"2008","journal-title":"Nat Med"},{"key":"R9-5-20210227","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","article-title":"Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor","volume":"333","author":"Walter","year":"1995","journal-title":"N Engl J Med"},{"key":"R10-5-20210227","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nri1842","article-title":"Adoptive immunotherapy for cancer: building on success","volume":"6","author":"Gattinoni","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"R11-5-20210227","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/01.cji.0000158855.92792.7a","article-title":"Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression","volume":"28","author":"Huang","year":"2005","journal-title":"J Immunother"},{"key":"R12-5-20210227","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1182\/blood-2004-06-2482","article-title":"Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy","volume":"105","author":"Powell","year":"2005","journal-title":"Blood"},{"key":"R13-5-20210227","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1172\/JCI24480","article-title":"Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells","volume":"115","author":"Gattinoni","year":"2005","journal-title":"J Clin Invest"},{"key":"R14-5-20210227","doi-asserted-by":"crossref","first-page":"9571","DOI":"10.1073\/pnas.0503726102","article-title":"Central memory self\/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells","volume":"102","author":"Klebanoff","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"R15-5-20210227","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/CJI.0b013e31818403d5","article-title":"Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy","volume":"31","author":"Tran","year":"2008","journal-title":"J Immunother"},{"key":"R16-5-20210227","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1129003","article-title":"Cancer regression in patients after transfer of genetically engineered lymphocytes","volume":"314","author":"Morgan","year":"2006","journal-title":"Science"},{"key":"R17-5-20210227","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/nri959","article-title":"Progressive differentiation and selection of the fittest in the immune response","volume":"2","author":"Lanzavecchia","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"R18-5-20210227","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nm0402-379","article-title":"Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections","volume":"8","author":"Appay","year":"2002","journal-title":"Nat Med"},{"key":"R19-5-20210227","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1084\/jem.20040717","article-title":"CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patients","volume":"200","author":"Ochsenbein","year":"2004","journal-title":"J Exp Med"},{"key":"R20-5-20210227","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.4049\/jimmunol.174.12.7497","article-title":"A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen-presenting cells","volume":"174","author":"Xiang","year":"2005","journal-title":"J Immunol"},{"key":"R21-5-20210227","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.4049\/jimmunol.175.10.7046","article-title":"Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy","volume":"175","author":"Zhou","year":"2005","journal-title":"J Immunol"},{"key":"R22-5-20210227","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1009","article-title":"Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells","volume":"4","author":"Kaech","year":"2003","journal-title":"Nat Immunol"},{"key":"R23-5-20210227","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/35040504","article-title":"Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function","volume":"408","author":"Parrish-Novak","year":"2000","journal-title":"Nature"},{"key":"R24-5-20210227","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.0105-2896.2004.00201.x","article-title":"Biology of IL-21 and the IL-21 receptor","volume":"202","author":"Mehta","year":"2004","journal-title":"Immunol Rev"},{"key":"R25-5-20210227","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.4049\/jimmunol.178.5.2827","article-title":"IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production","volume":"178","author":"Coquet","year":"2007","journal-title":"J Immunol"},{"key":"R26-5-20210227","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1182\/blood-2007-09-113050","article-title":"IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy","volume":"111","author":"Hinrichs","year":"2008","journal-title":"Blood"},{"key":"R27-5-20210227","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.4049\/jimmunol.175.4.2261","article-title":"IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response","volume":"175","author":"Li","year":"2005","journal-title":"J Immunol"},{"key":"R28-5-20210227","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1158\/1078-0432.CCR-08-1146","article-title":"Dissociation of its opposing immunologic effects is critical for the optimization of antitumor CD8+ T-cell responses induced by interleukin 21","volume":"14","author":"Ansen","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R29-5-20210227","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1182\/blood-2003-03-0669","article-title":"Interleukin-21 inhibits dendritic cell activation and maturation","volume":"102","author":"Brandt","year":"2003","journal-title":"Blood"},{"key":"R30-5-20210227","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/CJI.0b013e318046f3b1","article-title":"Autologous designer antigen-presenting cells by gene modification of T lymphocyte blasts with IL-7 and IL-12","volume":"30","author":"Foster","year":"2007","journal-title":"J Immunother"},{"key":"R31-5-20210227","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1182\/blood-2004-03-1208","article-title":"Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1","volume":"105","author":"Cooper","year":"2005","journal-title":"Blood"},{"key":"R32-5-20210227","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1182\/blood-2008-07-168666","article-title":"Peripheral blood lymphocytes genetically modified to express the self\/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients","volume":"113","author":"Fontana","year":"2009","journal-title":"Blood"},{"key":"R33-5-20210227","first-page":"95","article-title":"Expression of RHAMM\/CD168 and other tumor-associated antigens in patients with B-cell chronic lymphocytic leukemia","volume":"29","author":"Giannopoulos","year":"2006","journal-title":"Int J Oncol"},{"key":"R34-5-20210227","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1182\/blood-2002-05-1514","article-title":"Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies","volume":"101","author":"Gottschalk","year":"2003","journal-title":"Blood"},{"key":"R35-5-20210227","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4049\/jimmunol.142.2.702","article-title":"Signaling through T lymphocyte surface proteins, TCR\/CD3 and CD28, activates the HIV-1 long terminal repeat","volume":"142","author":"Tong-Starkesen","year":"1989","journal-title":"J Immunol"},{"key":"R36-5-20210227","doi-asserted-by":"crossref","first-page":"11170","DOI":"10.1128\/JVI.77.20.11170-11179.2003","article-title":"T-cell receptor\/CD28 engagement when combined with prostaglandin E2 treatment leads to potent activation of human T-cell leukemia virus type 1","volume":"77","author":"Dumais","year":"2003","journal-title":"J Virol"},{"key":"R37-5-20210227","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.4049\/jimmunol.160.4.1750","article-title":"Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A\/MART-1 immunodominant peptide analogues","volume":"160","author":"Valmori","year":"1998","journal-title":"J Immunol"},{"key":"R38-5-20210227","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1082305","article-title":"Requirement for CD4 T cell help in generating functional CD8\u2009T cell memory","volume":"300","author":"Shedlock","year":"2003","journal-title":"Science"},{"key":"R39-5-20210227","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature04790","article-title":"Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells","volume":"441","author":"Williams","year":"2006","journal-title":"Nature"},{"key":"R40-5-20210227","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"R41-5-20210227","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1126\/science.290.5489.92","article-title":"Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells","volume":"290","author":"Lanzavecchia","year":"2000","journal-title":"Science"},{"key":"R42-5-20210227","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1073\/pnas.0813101106","article-title":"Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains","volume":"106","author":"Carpenito","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R43-5-20210227","doi-asserted-by":"crossref","first-page":"900","DOI":"10.4049\/jimmunol.173.2.900","article-title":"IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21","volume":"173","author":"Moroz","year":"2004","journal-title":"J Immunol"},{"key":"R44-5-20210227","doi-asserted-by":"crossref","first-page":"732","DOI":"10.4049\/jimmunol.178.2.732","article-title":"IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes","volume":"178","author":"Peluso","year":"2007","journal-title":"J Immunol"},{"key":"R45-5-20210227","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/mt.2008.249","article-title":"Local IL-21 promotes the therapeutic activity of effector T cells by decreasing regulatory T cells within the tumor microenvironment","volume":"17","author":"Kim-Schulze","year":"2009","journal-title":"Mol Ther"}],"container-title":["Journal of Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CJI.0b013e3181ad4071","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:55:10Z","timestamp":1786038910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002371-200909000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/cji.0b013e3181ad4071","relation":{},"ISSN":["1524-9557"],"issn-type":[{"value":"1524-9557","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}